TY - JOUR T1 - Personalised medicine: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is cost effective in spondyloarthritis and psoriatic arthritis JF - Clinical Medicine JO - Clin Med SP - 108 LP - 109 DO - 10.7861/clinmedicine.19-2-s108 VL - 19 IS - Suppl 2 AU - Sayam Dubash AU - Domini Bryer AU - Andrew Barr AU - John Fitton AU - Claire Wenham AU - Helena Marzo-Ortega AU - Jane Freeston Y1 - 2019/03/01 UR - http://www.rcpjournals.org/content/19/Suppl_2/108.abstract ER -